532 related articles for article (PubMed ID: 33653505)
1. Prepped for PrEP? Acceptability, continuation and adherence among men who have sex with men and transgender women enrolled as part of Vietnam's first pre-exposure prophylaxis program.
Green KE; Nguyen LH; Phan HTT; Vu BN; Tran MH; Ngo HV; Tieu VTT; Van H; Le TM; Do KQ; Nguyen PA; Ngo TM; Doan AH; Bui DTN; Nguyen TNN; Hang LTX; Tran TT; Luong BQ
Sex Health; 2021 Mar; 18(1):104-115. PubMed ID: 33653505
[TBL] [Abstract][Full Text] [Related]
2. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens.
Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.
Konda KA; Torres TS; Mariño G; Ramos A; Moreira RI; Leite IC; Cunha M; Jalil EM; Hoagland B; Guanira JV; Benedetti M; Pimenta C; Vermandere H; Bautista-Arredondo S; Vega-Ramirez H; Veloso VG; Caceres CF; Grinsztejn B;
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25974. PubMed ID: 36225148
[TBL] [Abstract][Full Text] [Related]
5. Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol.
Sahay S; Bangar S; Chandhiok N
PLoS One; 2023; 18(6):e0287454. PubMed ID: 37352188
[TBL] [Abstract][Full Text] [Related]
6. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project.
Sullivan PS; Phaswana-Mafuya N; Baral SD; Valencia R; Zahn R; Dominguez K; Yah CS; Jones J; Kgatitswe LB; McNaghten AD; Siegler AJ; Sanchez TH; Bekker LG
J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25591. PubMed ID: 33000918
[TBL] [Abstract][Full Text] [Related]
7. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
[TBL] [Abstract][Full Text] [Related]
8. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand.
Phanuphak N; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Seekaew P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Na Nakorn PR; Mills S; Avery M; Vannakit R; Phanuphak P
Sex Health; 2018 Nov; 15(6):542-555. PubMed ID: 30249317
[TBL] [Abstract][Full Text] [Related]
9. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
[TBL] [Abstract][Full Text] [Related]
10. Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women.
Seekaew P; Nguyen E; Sungsing T; Jantarapakde J; Pengnonyang S; Trachunthong D; Mingkwanrungruang P; Sirisakyot W; Phiayura P; Panpet P; Meekrua P; Praweprai N; Suwan F; Sangtong S; Brutrat P; Wongsri T; Nakorn PRN; Mills S; Avery M; Vannakit R; Phanuphak P; Phanuphak N
BMC Public Health; 2019 Mar; 19(1):328. PubMed ID: 30898095
[TBL] [Abstract][Full Text] [Related]
11. Demand creation and retention strategies for oral pre-exposure prophylaxis for HIV prevention among men who have sex with men and transgender women: a systematic review and meta-analysis.
Guimarães NS; Magno L; Monteiro GMB; Ramos ICN; de Castro CT; Aranha-Rossi TR; Pereira M; Dourado I
BMC Infect Dis; 2023 Nov; 23(1):793. PubMed ID: 37964202
[TBL] [Abstract][Full Text] [Related]
12. Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.
Veloso VG; Cáceres CF; Hoagland B; Moreira RI; Vega-Ramírez H; Konda KA; Leite IC; Bautista-Arredondo S; Vinícius de Lacerda M; Valdez Madruga J; Farias A; Lima JN; Zonta R; Lauria L; Tamayo CVO; Flores HJS; Santa Cruz YMC; Aguayo RMM; Cunha M; Moreira J; Makkeda AR; Díaz S; Guanira JV; Vermandere H; Benedetti M; Ingold HL; Pimenta MC; Torres TS; Grinsztejn B;
Lancet HIV; 2023 Feb; 10(2):e84-e96. PubMed ID: 36565708
[TBL] [Abstract][Full Text] [Related]
13. Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil.
Echeverría-Guevara A; Coelho LE; Veloso VG; Pimenta MC; Hoagland B; Moreira RI; Leite I; Jalil EM; Cardoso SW; Torres TS; Grinsztejn B
Braz J Infect Dis; 2023; 27(1):102733. PubMed ID: 36586721
[TBL] [Abstract][Full Text] [Related]
14. Limited awareness of pre-exposure prophylaxis among black men who have sex with men and transgender women in New York city.
Garnett M; Hirsch-Moverman Y; Franks J; Hayes-Larson E; El-Sadr WM; Mannheimer S
AIDS Care; 2018 Jan; 30(1):9-17. PubMed ID: 28791876
[TBL] [Abstract][Full Text] [Related]
15. PrEP interest and HIV-1 incidence among MSM and transgender women in coastal Kenya.
Kimani M; van der Elst EM; Chiro O; Oduor C; Wahome E; Kazungu W; Shally M; Rinke de Wit TF; Graham SM; Operario D; Sanders EJ
J Int AIDS Soc; 2019 Jun; 22(6):e25323. PubMed ID: 31194291
[TBL] [Abstract][Full Text] [Related]
16. HIV Prevention Services for Hispanic/Latino Persons in THRIVE, 2015-2020.
Bonacci RA; Tanner MR; Zhu W; Hayes T; Dominguez KL; Iqbal K; Wiener J; Drezner K; Jennings JM; Tsoi B; Wendell D; Hoover KW;
Am J Prev Med; 2023 Aug; 65(2):213-220. PubMed ID: 36872151
[TBL] [Abstract][Full Text] [Related]
17. PrEP for key populations: results from the first PrEP demonstration project in the Democratic Republic of the Congo.
Franks J; Teasdale C; Olsen H; Wang C; Mushimebele N; Tenda Mazala R; Tchissambou T; Malele Bazola F; Bingham T; Djomand G; Mukinda E; Ewetola R; Abrams E; Reidy W
AIDS Care; 2022 Mar; 34(3):359-362. PubMed ID: 34495772
[TBL] [Abstract][Full Text] [Related]
18. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam.
Doan AH; Vu CMH; Nguyen TT; Green KE; Phan HTT; Janamnuaysook R; Vu BN; Le TM; Do KQ; Tran TT; Ngo TM; Basu L; Tran LK; Humeau Z
J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25996. PubMed ID: 36225133
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of a community-led online-based HIV self-testing demonstration among cisgender men who have sex with men and transgender women in the Philippines during the COVID-19 pandemic: a retrospective cohort study.
Eustaquio PC; Figuracion R; Izumi K; Morin MJ; Samaco K; Flores SM; Brink A; Diones ML
BMC Public Health; 2022 Feb; 22(1):366. PubMed ID: 35189850
[TBL] [Abstract][Full Text] [Related]
20. Providing HIV pre-exposure prophylaxis to men who have sex with men and transgender women in hospitals and community-led clinics in Thailand: acceptance, patterns of use, trends in risk behaviors, and HIV incidence.
L C; M C; P N; T D; K T; P T; P S; P P; V P; J S; L D; N T; J N; M M
AIDS Care; 2023 Apr; 35(4):524-537. PubMed ID: 36726288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
